The final, formatted version of the article will be published soon.
OPINION article
Front. Oncol.
Sec. Cancer Molecular Targets and Therapeutics
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1466399
The Novel Role of MDM2 in the Diagnosis and Treatment of Dedifferentiated Liposarcoma
Provisionally accepted- 1 Department of Orthopedic Surgery, University of Yamanashi, Yamanashi, Japan
- 2 Saitama Medical University International Medical Center, Hidaka, Japan
- 3 Department of Radiology, Faculty of Medicine, University of Yamanashi, Chuo, Japan
- 4 National Hospital Organization (NHO) Kofu National Hospital, Kofu, Japan
- 5 Department of Health Sciences, School of Medicine, Shinshu University, Matsumoto, Nagano, Japan
Keywords: Dedifferentiated liposarcoma, Immunohistochemistry, fluorescence in situ hybridization, MDM2, Extraskeletal osteosarcoma
Received: 17 Jul 2024; Accepted: 30 Sep 2024.
Copyright: © 2024 Ichikawa, Kawasaki, Onohara, Kanno, Wako, Ochiai, Aoki and Haro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jiro Ichikawa, Department of Orthopedic Surgery, University of Yamanashi, Yamanashi, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.